IP Verse

Baxalta Incorporated patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Baxalta Incorporated opposed by its competitors

Explore Baxalta Incorporated's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3064508
Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture1
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3277718
Mar 24, 2021Dosage Regimen For Anti-Mif Antibodies1
EP3121266
Apr 22, 2020Oligopeptide-Free Cell Culture Media6
EP2739641
Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes1
EP3116534
May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders1
EP2652491
Nov 29, 2017Eluate Collection Using Conductivity Gradient1
EP2295547
Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression1
EP1974014
Apr 19, 2017Oligopeptide-Free Cell Culture Media6

Top competitors of Baxalta Incorporated

List of top competitors of Baxalta Incorporated based on patent oppositions.